A Member of the Cancer Information Network
Cancer Information by State:
  arrow Patient Home   arrow Professional Home   arrow Newsletters   arrow Feedback Survey  
Search:
Medline
CancerConsultants.com
Both
Main Menu
Quick Links
Information by Disease
Cancer News
Conference Coverage
Oncology Stocks
AZN$46.31-0.04 (-0.09%)
NVS$53.380.04 (0.07%)
SNY$32.91-0.05 (-0.15%)
GSK$45.280.14 (0.31%)
Conference Coverage
2007 Conference Coverage

Highlights from the 49th Annual Meeting of the American Society of Hematology (ASH) CME
December 8-11, 2007 - Atlanta, Georgia

Highlights from the 12th World Conference on Lung Cancer CME
September 2-6, 2007 - Seoul, Korea

14th European Cancer Conference of the European Cancer Organization (ECCO) CME
September 23-27, 2007 - Barcelona, Spain

MASCC/ISOO 20th International Symposium CME
June 28-30, 2007 - St. Gallen, Switzerland

9th World Congress on Gastrointestinal Cancers (WCGIC) CME
June 28-July 1, 2007 - Barcelona, Spain

43rd American Society of Clinical Oncology Annual Meeting CME
June 1-5, 2007 - Chicago, IL

2007 American Urological Association Annual Meeting
May 19-24, 2007 - Anaheim, CA

Oncology Nursing Society 32nd Annual Congress CME
April 24-27, 2007 - Las Vegas, NV

ASCO Prostate Cancer Symposium
February 22-24, 2007 - Orlando, Florida

2007 Gastrointestinal Cancers Symposium CME
January 19-21, 2007 - Orlando, Florida

Newsletters
Register in our member center today to receive a monthly newsletter with conference coverage updates.
Learn More »
Practice Resources
Learn how to have our conference coverage on your website.
Learn More »
Related News Stories
Picoplatin, a Third Generation Platinum Compound, Evaluated for SCLC, Prostate Cancer and Colorectal Cancer (7/13/2007)

Alimta®/Platinum-compound Combination Confirmed Active in Mesothelioma (6/28/2007)

Adjuvant Gleevec® May Prevent Recurrences in Resected GIST (6/26/2007)

Addition of Avastin® to Gemzar®/Platinol® Combination Improves Progression-free Survival in NSCLC (6/22/2007)

Axitinib May Be Effective in Advanced Thyroid Cancer (6/21/2007)

Avastin® Improves Progression-Free Survival in Metastatic Renal Cell Cancer (6/20/2007)

Intravenous Iron Improves Clinical Outcomes of Aranesp® Treatment of Chemotherapy-Induced Anemia (6/20/2007)

Axitinib plus Taxotere® Maybe Superior to Taxotere alone for Metastatic Breast Cancer (6/19/2007)

Dose- Dense Adjuvant Chemotherapy Supported by Epoetin Alfa for Breast Cancer not Associated with Increased Relapses (6/18/2007)

Oncotype DX™ Evaluated in Node-positive Breast Cancer (6/18/2007)

Axitinib, an Oral Tyrosine Kinase Inhibitor, has Activity in NSCLC (6/15/2007)

Satraplatin Effective for Treatment of Hormone Refractory Prostate Cancer (6/15/2007)

Intermittent Androgen Suppression Confirmed Effective in Advanced Prostate Cancer (6/14/2007)

Ginseng May Improve Cancer-Related Fatigue (6/14/2007)

MRI May Improve Detection of DCIS (6/13/2007)

Adjuvant Herceptin-related Heart Problems Defined (6/13/2007)

Nilotinib Effective in Patients with CML Intolerant to Gleevec® (6/12/2007)

Bosutinib: A New Kinase Inhibitor for Treatment of Philadelphia Chromosome Positive Leukemia (6/12/2007)

AMG 531 Maybe Effective in Treating Thrombocytopenia in Patients with MDS (6/11/2007)

Sprycel® Highly Effective as Initial Therapy in Chronic Myeloid Leukemia (6/7/2007)

Recurrence Rates for Liver Metastases Reduced When Neoadjuvant and Adjuvant Chemotherapy are Used With Surgery (6/6/2007)

Erbitux® Improves Survival in Head and Neck Cancer (6/6/2007)

Prophylactic Cranial Radiation Improves Survival in Extensive Small-Cell Lung Cancer (6/5/2007)

Nexavar® Improves Survival in Hepatocellular Carcinoma (6/5/2007)

Oncotype DX™ Influences Breast Cancer Treatment Choices (6/4/2007)

Cryoablation as Salvage Therapy for Recurrent Prostate Cancer after Radiation (6/1/2007)

High Intensity Ultrasound for the Treatment of Localized Prostate Cancer to be Studied in the US (5/31/2007)

Randomized Trial Indicates that Cryosurgery is Equivalent to Radiation Therapy for Prostate Cancer (5/30/2007)

Oral Satraplatin well Tolerated and Effective for Metastatic Prostate Cancer (5/29/2007)

Functional Outcomes of Robotic Prostatectomy Similar to Conventional Prostatectomy (5/29/2007)

Weekly Taxol®, Eloxatin®, Leucovorin and 5-FU Promising for Metastatic Pancreatic Cancer (3/23/2007)

Aranesp® Every 2 or 3 Weeks Confirmed as Effective as Weekly Schedule (3/12/2007)

Adjuvant Platinol®/Navelbine® Improves Survival in NSCLC (10/11/2006)

Statin Use May Lower Risk of Aggressive Prostate Cancer (1/19/2006)
Additional Resources
Information by Cancer Type



© 1998-2007 CancerConsultants.com  All Rights Reserved.